---
title: "Galmed Pharmaceuticals holds annual shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297953499.md"
description: "Galmed Pharmaceuticals held its annual general meeting of shareholders on September 3, 2026. Shareholders adopted all proposals outlined in the meeting's proxy materials. The filing confirms the approval of these resolutions rather than their execution."
datetime: "2026-09-03T20:10:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297953499.md)
  - [en](https://longbridge.com/en/news/297953499.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297953499.md)
generator: "portal-rs"
---

# Galmed Pharmaceuticals holds annual shareholder meeting

-   Galmed held its annual general meeting of shareholders on Sept. 3, 2026. \* Shareholders adopted all proposals described in the meeting’s proxy materials. \* The filing confirms approval of the resolutions, not their execution. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-041357), on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [GLMD.US](https://longbridge.com/en/quote/GLMD.US.md)
- [EOCN.US](https://longbridge.com/en/quote/EOCN.US.md)

## Related News & Research

- [Galmed Pharmaceuticals Posts Higher R&D Spend and Shrinking Cash in Q2 2026](https://longbridge.com/en/news/297833520.md)
- [Galmed says Colospan intraoperative colon tissue assessment study meets feasibility goal in first-in-human trial](https://longbridge.com/en/news/296343802.md)
- [Datavault AI Says 2025, 2026 Financial Statements Can No Longer Be Relied Upon](https://longbridge.com/en/news/303126308.md)
- [PayPal Q3 2026 non-GAAP EPS rises 8% year over year to $1.45](https://longbridge.com/en/news/303217163.md)
- [Verizon CEO Says SpaceX May Be Years Away From Becoming America's 'Sixth' Wireless Competitor](https://longbridge.com/en/news/303109070.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**